(Q45915234)

English

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.

scientific article published in November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

1 reference

based on heuristic

inferred from title

author name string

Jean-Louis Alberini

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Florence Lerebours

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Myriam Wartski

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Emmanuelle Fourme

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Elise Le Stanc

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

E Gontier

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

O Madar

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

P Cherel

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

A P Pecking

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

115

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

21

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

5038-5047

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

21 January 2018

Inflammatory breast cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on the management of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Revision of the American Joint Committee on Cancer staging system for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory breast carcinoma: pathological or clinical entity?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

F-18 FDG uptake in breast infection and inflammation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining the clinical diagnosis of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory breast cancer: clinical progress and the main problems that must be addressed

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolving role of imaging modalities in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24534

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45915234&oldid=1514287211"